跳至主要内容
临床试验/CTRI/2026/01/101607
CTRI/2026/01/101607招募中2 期

A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY TO ASSESS THE EFFECT OF KUNJAL KRIYA AND LAJASATTU IN AMLAPITTA HYPERACIDITY

Institute for Ayurved studies and research1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年2月1日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
It will be assessed on the basis of statistical analysis applied on subjective parameter after completion of trial

研究概览

简要总结

Amlapitta (hyperacidity) is a common gastrointestinal disorder described in Ayurveda, primarily resulting from vitiation of Pitta dosha due to improper diet, lifestyle, and stress. Conventional management often provides temporary relief and may be associated with adverse effects, highlighting the need for safe and effective alternative approaches. This randomized open-label comparative clinical study was designed to assess and compare the therapeutic effects of Kunjal Kriya (a yogic cleansing practice) and Laja Sattu (a classical Ayurvedic dietary formulation) in the management of Amlapitta.

Patients diagnosed with Amlapitta were randomly allocated into two groups. One group received Kunjal Kriya as per standard yogic guidelines, while the other group was administered Laja Sattu for a specified duration. The assessment was based on subjective parameters such as heartburn, sour belching, nausea, epigastric pain, and heaviness, along with relevant objective parameters.

The study aimed to evaluate the comparative efficacy, safety, and clinical applicability of both interventions. Findings indicated that both Kunjal Kriya and Laja Sattu were effective in reducing the symptoms of Amlapitta, with variations in the degree of relief. The study concludes that these traditional, non-pharmacological approaches can play a significant role in the holistic management of Amlapitta.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 40.00 Year(s)(—)
性别
All

入选标准

  • Patients having classical symptoms of Amlapitta.
  • Patients of either sex and between 20-40 years of age Patients willing and able to carry out treatment for 4 weeks Patients will be registered with duly signed informed consent prior to the trial.

排除标准

  • Patients with diagnosed cases of gastric, peptic and duodenal ulcers Patients with any GIT abdominal complications and chronic illnes Patient taking drug such as NSAIDs which is supposed to increase acid production and gastric ulcerations History of esophageal varices and hematemesis Patients not willing to participate in a clinical study Pregnant and lactating women are avoided for study.

结局指标

主要结局

It will be assessed on the basis of statistical analysis applied on subjective parameter after completion of trial

时间窗: 4 weeks

次要结局

  • Improvement in quality of life(Safety & tolerability of Kunjal Kriya and Lajasattu)

研究者

发起方
Institute for Ayurved studies and research
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Ravi Pawar

Institute for ayurved studies and Research

研究点 (1)

Loading locations...

相似试验